Becton, dickinson and company:1106636 [20-006943]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00268
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,818
Award facts
- Contract value 100% obligated
- $2,817.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95131, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,920 | |
| Funding Only Action | -$213 | |
| Other Administrative Action | $0 | |
| Original award | $5,950 |
About this award
This contract award represents an administrative de-obligation action by the NIH Clinical Center to recover and process unexpended and expiring Fiscal Year 2021 funding totaling $2,817.75 from Becton, Dickinson and Company (BD Biosciences division). The action, executed on March 6, 2020, with an ultimate completion date of April 5, 2021, is a firm fixed-price purchase order with no small business set-aside utilized. This de-obligation is conducted in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The performance location is identified as San Jose, California.
BD Biosciences, operating under parent company Becton, Dickinson and Company, is a leading global supplier of flow cytometry systems, diagnostic equipment, and associated laboratory reagents to federal agencies. The company maintains an extensive portfolio of indefinite delivery vehicles with the NIH Clinical Center and other federal agencies, including a $1.25 million single-award indefinite delivery contract with the NIH Clinical Center valued through December 2026 with optional extensions through 2029. This de-obligation action reflects routine fiscal management and fund recovery procedures related to BD's broader supply relationship with the NIH Clinical Center for hematology flow cytometry services, instrumentation packages, and laboratory supplies supporting biomedical research and clinical diagnostic operations.
Quick answers
Who was awarded contract 75N90020P00268?
75N90020P00268 was awarded to Becton, Dickinson And Company by NIH Clinical Center (National Institutes of Health) on March 6, 2020.
How much is contract 75N90020P00268 worth?
The government has obligated $2,818 on 75N90020P00268.
Was contract 75N90020P00268 competed?
The extent of competition for 75N90020P00268 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award